Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iHisto is a private histology and histopathology contract research organization serving academic labs, biotech companies, pharmaceutical companies, CROs, and pathology groups. The company provides tissue processing, routine histology, special stains, immunohistochemistry, immunofluorescence, in situ hybridization, spatial biology, whole-slide imaging, quantitative image analysis, and pathology review/reporting. iHisto positions itself as a GLP-compliant preclinical pathology partner with rapid turnaround and digital pathology capabilities for preclinical and translational research. Its business is service-based rather than therapeutics-focused, with support spanning pilot studies through large multi-thousand-slide programs. The company appears to operate from Salem, Massachusetts in the Greater Boston biotech hub and markets cloud-enabled digital pathology through its HistoCloud offering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iHisto.